Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540852 · ClinicalTrials.gov registry record · NA
Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT00540852: Completed NA study, sponsored by University of California, Irvine.
NCT00540852 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00540852, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
Optimal management of patients with locally advanced breast cancer remains a complex therapeutic problem. Newly diagnosed breast cancers in the United States with a higher incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant chemotherapy still remains controversial due to the difficulty of evaluating response to therapy. The goal would be to prevent over and under treatment of patients with neoadjuvant chemotherapy.
Primary Outcome
Diffuse Optical Spectroscopy Imaging Breast Cancer Tumor in the response of Chemotherapy
Interventions
- DEVICE Diffuse Optical Spectroscopy Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2002-06 |
| Est. Completion | 2011-01 |
| Phase | NA |
What the finished NCT00540852 record still lists
NCT00540852 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy Imaging is the first listed.
NCT00540852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00540852 about?
NCT00540852 is a clinical study titled "Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy". Optimal management of patients with locally advanced breast cancer remains a complex therapeutic problem. Newly diagnosed breast cancers in the United States with a higher incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant chemotherapy still remains controver...
What is the current status of trial NCT00540852?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2002-06. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00540852?
The interventions under investigation include: Diffuse Optical Spectroscopy Imaging (DEVICE).
Who is sponsoring clinical trial NCT00540852?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00540852's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia